摘要:
The invention relates to the use of specific compounds of formula (I) and their pharmaceutically-acceptable salts:(Formula 1) (I) as a new family of protein kinase CK2 inhibitors; the invention also relates to the use of compounds of formula (I) for the preparation of pharmaceutical compositions for the prevention and/or treatment of disorders and/or diseases chosen amongst cancers; autoimmune and inflammatory diseases; infectious diseases; diabetes angiogenesis related disorders; retinopathies and cardiac hypertrophy.
摘要:
The invention relates to the use of isoquinolones for preparing drugs, including novel isoquinolones. The invention also relates to said novel isoquinolones as well as to the method for synthesising same. In particular, the invention relates to isoquinolone derivatives used in the treatment of pathological angiogeneses, specifically cancer.
摘要:
The present invention relates to a new class of benzo[e]pyrido-indole, the amino-substituted-alkyloxy-benzo[e]pyrido[4,3-b]indole derivatives, having a particular kinase inhibition profile and useful as a therapeutic agent, in particular an anti-tumoral agent.